Gilles Martin
Directeur Général chez EUROFINS SCIENTIFIC SE
Fortune : 616 $ au 30/04/2024
Actualités sur Gilles Martin
Sociétés liées
Sociétés cotées | 2 |
---|---|
EUROFINS SCIENTIFIC SE | Commercial Services |
BRUKER CORPORATION | Health Technology |
Entreprise privées | 5 |
---|---|
Association Française Des Laboratoires D'Analyses Indépendant | |
Analytical Bioventures SCA
Analytical Bioventures SCA BiotechnologyHealth Technology Analytical Bioventures SCA operates as a holding company, which provides environmental research services. The company was founded on 11 October 2002 and is headquartered in Luxembourg. | Health Technology |
Bruker Daltonics, Inc.
Bruker Daltonics, Inc. BiotechnologyHealth Technology Bruker Daltonics, Inc. designs, manufactures and markets life sciences tools. The company was founded in 1980 and is headquartered in Billerica, MA. | Health Technology |
Eurofins GeneScan Holding GmbH
Eurofins GeneScan Holding GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins GeneScan Holding GmbH is a world leader in food, environment, pharma product testing & agroscience CRO services. The private company is based in Freiburg im Breisgau, Germany. With a network of more than 1,000 independent companies (900 laboratories) in 61 countries, Eurofins GeneScan Holding offers over 200,000 analytical methods. The CEO of the German company is Gilles G. Martin. | Commercial Services |
Eurofins Labazur Rhone-Alpes SELAS |
Formation de Gilles Martin
École Centrale Paris | Undergraduate Degree |
Syracuse University | Doctorate Degree |
- Bourse
- Insiders
- Gilles Martin
- Actualités